{"id":1664,"date":"2025-09-01T16:01:37","date_gmt":"2025-09-01T14:01:37","guid":{"rendered":"https:\/\/flo.org.pl\/?p=1664"},"modified":"2025-10-17T13:57:19","modified_gmt":"2025-10-17T11:57:19","slug":"semaglutyd-zatwierdzony-do-leczenia-mash","status":"publish","type":"post","link":"https:\/\/flo.org.pl\/index.php\/2025\/09\/01\/semaglutyd-zatwierdzony-do-leczenia-mash\/","title":{"rendered":"Semaglutyd zatwierdzony do leczenia MASH"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">FDA (Agencja ds. \u017bywno\u015bci i Lek\u00f3w w USA) wyda\u0142a przyspieszon\u0105 zgod\u0119 na stosowanie leku <a href=\"https:\/\/www.facebook.com\/hashtag\/wegovy?__eep__=6&amp;__cft__[0]=AZUjrrEDNR4-a0-ol6cFWncYz2ESHlOASsUtF9QH1SOEd2jgGQwW2Men-ZZ7hbohYug3L-FrGJcLi_OBj44E_gyIzFAOHM-6bCxx77Dota-a6ixCTVFBwCI0ToZce7IrNnbruyoTN8YhMwVPPJykS7qRTpugA4m8viwI3OUSkEuM8OFrPI8biYBDYzHDtCKTvzk&amp;__tn__=*NK-R\">#Wegovy<\/a> (semaglutyd 2,4 mg) w leczeniu st\u0142uszczeniowego zapalenia w\u0105troby o <a><\/a>pod\u0142o\u017cu metabolicznym (MASH) u doros\u0142ych z umiarkowanym lub zaawansowanym w\u0142\u00f3knieniem &#8211; podaje portal <a href=\"https:\/\/www.facebook.com\/Termedia?__cft__[0]=AZUjrrEDNR4-a0-ol6cFWncYz2ESHlOASsUtF9QH1SOEd2jgGQwW2Men-ZZ7hbohYug3L-FrGJcLi_OBj44E_gyIzFAOHM-6bCxx77Dota-a6ixCTVFBwCI0ToZce7IrNnbruyoTN8YhMwVPPJykS7qRTpugA4m8viwI3OUSkEuM8OFrPI8biYBDYzHDtCKTvzk&amp;__tn__=-]K-R\">Termedia<\/a>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><img decoding=\"async\" height=\"16\" width=\"16\" alt=\"\ud83d\udcca\" src=\"https:\/\/static.xx.fbcdn.net\/images\/emoji.php\/v9\/taa\/1\/16\/1f4ca.png\"> Wyniki badania fazy 3 ESSENCE pokaza\u0142y, \u017ce:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">&#8211; u 63% os\u00f3b leczonych Wegovy dosz\u0142o do ust\u0105pienia MASH bez pogorszenia w\u0142\u00f3knienia (vs. 34% placebo),<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">&#8211; u 37% zaobserwowano popraw\u0119 w\u0142\u00f3knienia w\u0105troby (vs. 22% placebo).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">To prze\u0142omowe dane dla os\u00f3b z chorob\u0105 oty\u0142o\u015bciow\u0105, bo a\u017c 1 na 3 osoby z nadwag\u0105 lub oty\u0142o\u015bci\u0105 na \u015bwiecie cierpi r\u00f3wnie\u017c na MASH.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Wegovy jest ju\u017c znany jako lek wspieraj\u0105cy redukcj\u0119 masy cia\u0142a (r\u00f3wnie\u017c w\u015br\u00f3d dzieci powy\u017cej 12 roku \u017cycia) i zmniejszaj\u0105cy ryzyko zdarze\u0144 sercowo-naczyniowych, a teraz otwiera nowe perspektywy w leczeniu chor\u00f3b w\u0105troby.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>FDA (Agencja ds. \u017bywno\u015bci i Lek\u00f3w w USA) wyda\u0142a przyspieszon\u0105 zgod\u0119 na stosowanie leku #Wegovy (semaglutyd 2,4 mg) w leczeniu st\u0142uszczeniowego zapalenia w\u0105troby o pod\u0142o\u017cu metabolicznym (MASH) u doros\u0142ych z &hellip; <\/p>\n","protected":false},"author":4,"featured_media":1665,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[19],"tags":[],"class_list":["post-1664","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-badania","has-meta has-sticky-meta"],"rttpg_featured_image_url":{"full":["https:\/\/flo.org.pl\/wp-content\/uploads\/2025\/09\/MASH_WEGOVY.png",1080,1080,false],"landscape":["https:\/\/flo.org.pl\/wp-content\/uploads\/2025\/09\/MASH_WEGOVY.png",1080,1080,false],"portraits":["https:\/\/flo.org.pl\/wp-content\/uploads\/2025\/09\/MASH_WEGOVY.png",1080,1080,false],"thumbnail":["https:\/\/flo.org.pl\/wp-content\/uploads\/2025\/09\/MASH_WEGOVY-150x150.png",150,150,true],"medium":["https:\/\/flo.org.pl\/wp-content\/uploads\/2025\/09\/MASH_WEGOVY-300x300.png",300,300,true],"large":["https:\/\/flo.org.pl\/wp-content\/uploads\/2025\/09\/MASH_WEGOVY-1024x1024.png",740,740,true],"post-slider-thumb-size":["https:\/\/flo.org.pl\/wp-content\/uploads\/2025\/09\/MASH_WEGOVY-330x190.png",330,190,true],"post-category-slider-size":["https:\/\/flo.org.pl\/wp-content\/uploads\/2025\/09\/MASH_WEGOVY-330x350.png",330,350,true],"1536x1536":["https:\/\/flo.org.pl\/wp-content\/uploads\/2025\/09\/MASH_WEGOVY.png",1080,1080,false],"2048x2048":["https:\/\/flo.org.pl\/wp-content\/uploads\/2025\/09\/MASH_WEGOVY.png",1080,1080,false],"coachpress-lite-classic":["https:\/\/flo.org.pl\/wp-content\/uploads\/2025\/09\/MASH_WEGOVY-700x433.png",700,433,true],"coachpress-lite-classic-full":["https:\/\/flo.org.pl\/wp-content\/uploads\/2025\/09\/MASH_WEGOVY-1080x724.png",1080,724,true],"coachpress-lite-grid":["https:\/\/flo.org.pl\/wp-content\/uploads\/2025\/09\/MASH_WEGOVY-320x198.png",320,198,true],"coachpress-lite-grid-full":["https:\/\/flo.org.pl\/wp-content\/uploads\/2025\/09\/MASH_WEGOVY-535x331.png",535,331,true],"coachpress-lite-promo":["https:\/\/flo.org.pl\/wp-content\/uploads\/2025\/09\/MASH_WEGOVY-370x424.png",370,424,true],"coachpress-lite-service":["https:\/\/flo.org.pl\/wp-content\/uploads\/2025\/09\/MASH_WEGOVY-544x350.png",544,350,true],"coachpress-lite-client":["https:\/\/flo.org.pl\/wp-content\/uploads\/2025\/09\/MASH_WEGOVY-330x190.png",330,190,true],"coachpress-lite-slider":["https:\/\/flo.org.pl\/wp-content\/uploads\/2025\/09\/MASH_WEGOVY-1080x550.png",1080,550,true],"coachpress-lite-single":["https:\/\/flo.org.pl\/wp-content\/uploads\/2025\/09\/MASH_WEGOVY-740x456.png",740,456,true],"coachpress-lite-single-full":["https:\/\/flo.org.pl\/wp-content\/uploads\/2025\/09\/MASH_WEGOVY-1080x768.png",1080,768,true]},"rttpg_author":{"display_name":"Katarzyna Kunert","author_link":"https:\/\/flo.org.pl\/index.php\/author\/katarzyna-kunert\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/flo.org.pl\/index.php\/category\/badania\/\" rel=\"category tag\">BADANIA<\/a>","rttpg_excerpt":"FDA (Agencja ds. \u017bywno\u015bci i Lek\u00f3w w USA) wyda\u0142a przyspieszon\u0105 zgod\u0119 na stosowanie leku #Wegovy (semaglutyd 2,4 mg) w leczeniu st\u0142uszczeniowego zapalenia w\u0105troby o pod\u0142o\u017cu metabolicznym (MASH) u doros\u0142ych z &hellip;","_links":{"self":[{"href":"https:\/\/flo.org.pl\/index.php\/wp-json\/wp\/v2\/posts\/1664","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flo.org.pl\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flo.org.pl\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flo.org.pl\/index.php\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/flo.org.pl\/index.php\/wp-json\/wp\/v2\/comments?post=1664"}],"version-history":[{"count":1,"href":"https:\/\/flo.org.pl\/index.php\/wp-json\/wp\/v2\/posts\/1664\/revisions"}],"predecessor-version":[{"id":1666,"href":"https:\/\/flo.org.pl\/index.php\/wp-json\/wp\/v2\/posts\/1664\/revisions\/1666"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flo.org.pl\/index.php\/wp-json\/wp\/v2\/media\/1665"}],"wp:attachment":[{"href":"https:\/\/flo.org.pl\/index.php\/wp-json\/wp\/v2\/media?parent=1664"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flo.org.pl\/index.php\/wp-json\/wp\/v2\/categories?post=1664"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flo.org.pl\/index.php\/wp-json\/wp\/v2\/tags?post=1664"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}